I-Mab Current Ratio 2020-2021 | IMAB
I-Mab current ratio from 2020 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
|I-Mab Current Ratio Historical Data
||Medical - Biomedical and Genetics
I-Mab is a clinical stage biopharmaceutical company. It engages in discovery, development and commercialization of biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. I-Mab is based in SHANGHAI, China.